1. CXCL12-driven thymocyte migration is increased by thymic epithelial cells treated with prolactin in vitro .
- Author
-
Medeiros NVC, Porto FL, DE Menezes CA, Santos Reis MDD, Smaniotto S, and Lins MP
- Subjects
- Actins metabolism, Animals, Cell Adhesion drug effects, Cell Movement drug effects, Cells, Cultured, Cytoskeleton drug effects, Epithelial Cells, Extracellular Matrix drug effects, Female, Fibronectins metabolism, Male, Mice, Inbred C57BL, Thymocytes drug effects, Thymocytes physiology, Mice, Chemokine CXCL12 metabolism, Prolactin pharmacology, Thymocytes cytology, Thymus Gland cytology
- Abstract
The prolactin hormone (PRL), in addition to its known effects on breast development and lactation, exerts effects on the immune system, including pleiotropic effects on the thymus. The aim of this study was to evaluate the influence of PRL on the epithelial compartment of the thymus. Thymic epithelial cells (TECs) (2BH4 cells) and fresh thymocytes were used. Immunofluorescence assay revealed that PRL treatment (10 ng/ mL) increases the deposition of laminin and expression of the chemokine CXCL12 in 2BH4 cells. However, no change was observed in the deposition of fibronectin. Moreover, PRL altered F-actin polymerisation, allowing the formation of focal adhesion complexes in treated cells. When 2BH4 cells were pre-treated with PRL, thymocyte adhesion was not altered. However, in the cell migration assay, pre-treatment with PRL potentiated the chemotactic effect of CXCL12 on the migration of total, double-positive, CD4-positive, and CD8-positive thymocytes. Together, the results of this study demonstrate the effect of PRL on thymic epithelial cells, particularly on CXCL12-driven thymocyte migration, confirming that this hormone is a regulator of thymic physiology.
- Published
- 2021